disopyramide has been researched along with Abnormality, Heart in 4 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Luo, C | 1 |
Wang, K | 1 |
Zhang, H | 1 |
Yanaga, T | 1 |
Ichimaru, Y | 1 |
Ueno, T | 1 |
Hata, Y | 1 |
Okamoto, K | 1 |
Kodama, Y | 1 |
Otsuka, K | 1 |
Schöttelndreiër, MA | 1 |
Wolff, GS | 1 |
1 review available for disopyramide and Abnormality, Heart
Article | Year |
---|---|
Unexplained syncope: clinical management.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Behavior Ther | 1997 |
3 other studies available for disopyramide and Abnormality, Heart
Article | Year |
---|---|
Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
Topics: Action Potentials; Arrhythmias, Cardiac; Disopyramide; Heart Conduction System; Heart Defects, Conge | 2017 |
The usefulness of Holter monitoring in the evaluation of antiarrhythmic drug efficacy for tachycardia.
Topics: Adult; Aged; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Diltiazem; Disopyramide; Female; Hear | 1983 |
[Syncope associated with prolonged QT-interval on the electrocardiogram].
Topics: Adult; Aged; Disopyramide; Electrocardiography; Female; Heart Defects, Congenital; Humans; Syncope | 1981 |